首页> 美国卫生研究院文献>other >The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells
【2h】

The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells

机译:人骨关节炎软骨下骨成骨细胞中骨保护素(OPG)和核因子κB受体激活剂(RANKL)的差异表达是这些疾病细胞代谢状态的指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveWe previously reported that human OA subchondral bone osteoblasts could be discriminated into two subpopulations identified by their levels of endogenous production (low [L] or high [H]) of PGE2. Here, we investigated the OPG and RANKL expression levels, the histologic analysis of the subchondral bone as well as the osteoclast differentiation effect of osteoblasts on normal and both OA subpopulations (L and H), and further examined on the L OA osteoblasts the modulation of bone remodelling factors on the OPG and RANKL levels, as well as on the resorption activity.
机译:目的我们以前曾报道过,人OA软骨下成骨细胞可以分为两个亚群,这些亚群由它们的PGE2内源性产生水平(低[L]或高[H])确定。在这里,我们研究了OPG和RANKL的表达水平,软骨下骨的组织学分析以及成骨细胞对正常和OA亚群(L和H)的破骨细胞分化作用,并进一步研究了L OA成骨细胞对OA的调节骨重塑因素影响OPG和RANKL的水平以及吸收活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号